Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1996 Nov 30;313(7069):1385–1389. doi: 10.1136/bmj.313.7069.1385

Insulin resistance.

A J Krentz 1
PMCID: PMC2352942  PMID: 8956710

Full text

PDF
1385

Images in this article

1385Fig 1
on p.1385
1387Fig 3
on p.1387

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amiel S. A., Sherwin R. S., Simonson D. C., Lauritano A. A., Tamborlane W. V. Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med. 1986 Jul 24;315(4):215–219. doi: 10.1056/NEJM198607243150402. [DOI] [PubMed] [Google Scholar]
  2. Armstrong L., Bell P. M. Addison's disease presenting as reduced insulin requirement in insulin dependent diabetes. BMJ. 1996 Jun 22;312(7046):1601–1602. doi: 10.1136/bmj.312.7046.1601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bailey C. J., Turner R. C. Metformin. N Engl J Med. 1996 Feb 29;334(9):574–579. doi: 10.1056/NEJM199602293340906. [DOI] [PubMed] [Google Scholar]
  4. Banerji M. A., Chaiken R. L., Gordon D., Kral J. G., Lebovitz H. E. Does intra-abdominal adipose tissue in black men determine whether NIDDM is insulin-resistant or insulin-sensitive? Diabetes. 1995 Feb;44(2):141–146. doi: 10.2337/diab.44.2.141. [DOI] [PubMed] [Google Scholar]
  5. Barker D. J. Fetal origins of coronary heart disease. BMJ. 1995 Jul 15;311(6998):171–174. doi: 10.1136/bmj.311.6998.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Baron A. D. Hemodynamic actions of insulin. Am J Physiol. 1994 Aug;267(2 Pt 1):E187–E202. doi: 10.1152/ajpendo.1994.267.2.E187. [DOI] [PubMed] [Google Scholar]
  7. Beatty O. L., Harper R., Sheridan B., Atkinson A. B., Bell P. M. Insulin resistance in offspring of hypertensive parents. BMJ. 1993 Jul 10;307(6896):92–96. doi: 10.1136/bmj.307.6896.92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bell P. M. Clinical significance of insulin resistance. Diabet Med. 1996 Jun;13(6):504–509. doi: 10.1002/(SICI)1096-9136(199606)13:6<504::AID-DIA111>3.0.CO;2-P. [DOI] [PubMed] [Google Scholar]
  9. Björntorp P. Metabolic implications of body fat distribution. Diabetes Care. 1991 Dec;14(12):1132–1143. doi: 10.2337/diacare.14.12.1132. [DOI] [PubMed] [Google Scholar]
  10. Després J. P., Lamarche B., Mauriège P., Cantin B., Dagenais G. R., Moorjani S., Lupien P. J. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996 Apr 11;334(15):952–957. doi: 10.1056/NEJM199604113341504. [DOI] [PubMed] [Google Scholar]
  11. Dinneen S., Gerich J., Rizza R. Carbohydrate metabolism in non-insulin-dependent diabetes mellitus. N Engl J Med. 1992 Sep 3;327(10):707–713. doi: 10.1056/NEJM199209033271007. [DOI] [PubMed] [Google Scholar]
  12. Durrington P. N. Is insulin atherogenic? Diabet Med. 1992 Aug-Sep;9(7):597–600. doi: 10.1111/j.1464-5491.1992.tb01852.x. [DOI] [PubMed] [Google Scholar]
  13. Ferrannini E., Buzzigoli G., Bonadonna R., Giorico M. A., Oleggini M., Graziadei L., Pedrinelli R., Brandi L., Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med. 1987 Aug 6;317(6):350–357. doi: 10.1056/NEJM198708063170605. [DOI] [PubMed] [Google Scholar]
  14. Ferrannini E., Haffner S. M., Mitchell B. D., Stern M. P. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia. 1991 Jun;34(6):416–422. doi: 10.1007/BF00403180. [DOI] [PubMed] [Google Scholar]
  15. Ferrannini E., Vichi S., Beck-Nielsen H., Laakso M., Paolisso G., Smith U. Insulin action and age. European Group for the Study of Insulin Resistance (EGIR). Diabetes. 1996 Jul;45(7):947–953. doi: 10.2337/diab.45.7.947. [DOI] [PubMed] [Google Scholar]
  16. Fontbonne A., Charles M. A., Juhan-Vague I., Bard J. M., André P., Isnard F., Cohen J. M., Grandmottet P., Vague P., Safar M. E. The effect of metformin on the metabolic abnormalities associated with upper-body fat distribution. BIGPRO Study Group. Diabetes Care. 1996 Sep;19(9):920–926. doi: 10.2337/diacare.19.9.920. [DOI] [PubMed] [Google Scholar]
  17. Gerich J. E. Is muscle the major site of insulin resistance in type 2 (non-insulin-dependent) diabetes mellitus? Diabetologia. 1991 Aug;34(8):607–610. doi: 10.1007/BF00400282. [DOI] [PubMed] [Google Scholar]
  18. Godsland I. F., Stevenson J. C. Insulin resistance: syndrome or tendency? Lancet. 1995 Jul 8;346(8967):100–103. doi: 10.1016/s0140-6736(95)92118-4. [DOI] [PubMed] [Google Scholar]
  19. Groop L. C., Widén E., Ferrannini E. Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: errors of metabolism or of methods? Diabetologia. 1993 Dec;36(12):1326–1331. doi: 10.1007/BF00400814. [DOI] [PubMed] [Google Scholar]
  20. Harper R., Ennis C. N., Sheridan B., Atkinson A. B., Johnston G. D., Bell P. M. Effects of low dose versus conventional dose thiazide diuretic on insulin action in essential hypertension. BMJ. 1994 Jul 23;309(6949):226–230. doi: 10.1136/bmj.309.6949.226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hother-Nielsen O., Beck-Nielsen H. On the determination of basal glucose production rate in patients with type 2 (non-insulin-dependent) diabetes mellitus using primed-continuous 3-3H-glucose infusion. Diabetologia. 1990 Oct;33(10):603–610. doi: 10.1007/BF00400204. [DOI] [PubMed] [Google Scholar]
  22. Jarrett R. J. In defence of insulin: a critique of syndrome X. Lancet. 1992 Aug 22;340(8817):469–471. doi: 10.1016/0140-6736(92)91781-3. [DOI] [PubMed] [Google Scholar]
  23. Kahn C. R. Insulin resistance, insulin insensitivity, and insulin unresponsiveness: a necessary distinction. Metabolism. 1978 Dec;27(12 Suppl 2):1893–1902. doi: 10.1016/s0026-0495(78)80007-9. [DOI] [PubMed] [Google Scholar]
  24. Kiechl S., Willeit J., Poewe W., Egger G., Oberhollenzer F., Muggeo M., Bonora E. Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study) BMJ. 1996 Oct 26;313(7064):1040–1044. doi: 10.1136/bmj.313.7064.1040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Knowler W. C., Narayan K. M., Hanson R. L., Nelson R. G., Bennett P. H., Tuomilehto J., Scherstén B., Pettitt D. J. Preventing non-insulin-dependent diabetes. Diabetes. 1995 May;44(5):483–488. doi: 10.2337/diab.44.5.483. [DOI] [PubMed] [Google Scholar]
  26. Krentz A. J., Ferner R. E., Bailey C. J. Comparative tolerability profiles of oral antidiabetic agents. Drug Saf. 1994 Oct;11(4):223–241. doi: 10.2165/00002018-199411040-00002. [DOI] [PubMed] [Google Scholar]
  27. Krentz A. J., Nattrass M. Insulin resistance: a multifaceted metabolic syndrome. Insights gained using a low-dose insulin infusion technique. Diabet Med. 1996 Jan;13(1):30–39. doi: 10.1002/(SICI)1096-9136(199601)13:1<30::AID-DIA5>3.0.CO;2-I. [DOI] [PubMed] [Google Scholar]
  28. Krook A., O'Rahilly S. Mutant insulin receptors in syndromes of insulin resistance. Baillieres Clin Endocrinol Metab. 1996 Jan;10(1):97–122. doi: 10.1016/s0950-351x(96)80330-2. [DOI] [PubMed] [Google Scholar]
  29. Kumar S., Boulton A. J., Beck-Nielsen H., Berthezene F., Muggeo M., Persson B., Spinas G. A., Donoghue S., Lettis S., Stewart-Long P. Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Troglitazone Study Group. Diabetologia. 1996 Jun;39(6):701–709. doi: 10.1007/BF00418542. [DOI] [PubMed] [Google Scholar]
  30. Laws A., Reaven G. M. Insulin resistance and risk factors for coronary heart disease. Baillieres Clin Endocrinol Metab. 1993 Oct;7(4):1063–1078. doi: 10.1016/s0950-351x(05)80245-9. [DOI] [PubMed] [Google Scholar]
  31. Mauriège P., Bouchard C. Trp64Arg mutation in beta 3-adrenoceptor gene of doubtful significance for obesity and insulin resistance. Lancet. 1996 Sep 14;348(9029):698–699. doi: 10.1016/S0140-6736(05)65601-2. [DOI] [PubMed] [Google Scholar]
  32. McClain D. A., Crook E. D. Hexosamines and insulin resistance. Diabetes. 1996 Aug;45(8):1003–1009. doi: 10.2337/diab.45.8.1003. [DOI] [PubMed] [Google Scholar]
  33. Modan M., Halkin H., Almog S., Lusky A., Eshkol A., Shefi M., Shitrit A., Fuchs Z. Hyperinsulinemia. A link between hypertension obesity and glucose intolerance. J Clin Invest. 1985 Mar;75(3):809–817. doi: 10.1172/JCI111776. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Moller D. E., Bjørbaek C., Vidal-Puig A. Candidate genes for insulin resistance. Diabetes Care. 1996 Apr;19(4):396–400. doi: 10.2337/diacare.19.4.396. [DOI] [PubMed] [Google Scholar]
  35. Moller D. E., Flier J. S. Insulin resistance--mechanisms, syndromes, and implications. N Engl J Med. 1991 Sep 26;325(13):938–948. doi: 10.1056/NEJM199109263251307. [DOI] [PubMed] [Google Scholar]
  36. Nestler J. E., Jakubowicz D. J. Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med. 1996 Aug 29;335(9):617–623. doi: 10.1056/NEJM199608293350902. [DOI] [PubMed] [Google Scholar]
  37. Nolan J. J., Ludvik B., Beerdsen P., Joyce M., Olefsky J. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med. 1994 Nov 3;331(18):1188–1193. doi: 10.1056/NEJM199411033311803. [DOI] [PubMed] [Google Scholar]
  38. Ofei F., Hurel S., Newkirk J., Sopwith M., Taylor R. Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes. 1996 Jul;45(7):881–885. doi: 10.2337/diab.45.7.881. [DOI] [PubMed] [Google Scholar]
  39. Pais P., Pogue J., Gerstein H., Zachariah E., Savitha D., Jayprakash S., Nayak P. R., Yusuf S. Risk factors for acute myocardial infarction in Indians: a case-control study. Lancet. 1996 Aug 10;348(9024):358–363. doi: 10.1016/s0140-6736(96)02507-x. [DOI] [PubMed] [Google Scholar]
  40. Perseghin G., Price T. B., Petersen K. F., Roden M., Cline G. W., Gerow K., Rothman D. L., Shulman G. I. Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. N Engl J Med. 1996 Oct 31;335(18):1357–1362. doi: 10.1056/NEJM199610313351804. [DOI] [PubMed] [Google Scholar]
  41. Polonsky K. S., Sturis J., Bell G. I. Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med. 1996 Mar 21;334(12):777–783. doi: 10.1056/NEJM199603213341207. [DOI] [PubMed] [Google Scholar]
  42. RANDLE P. J., GARLAND P. B., HALES C. N., NEWSHOLME E. A. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963 Apr 13;1(7285):785–789. doi: 10.1016/s0140-6736(63)91500-9. [DOI] [PubMed] [Google Scholar]
  43. Rachman J., Turner R. C. Drugs on the horizon for treatment of type 2 diabetes. Diabet Med. 1995 Jun;12(6):467–478. doi: 10.1111/j.1464-5491.1995.tb00526.x. [DOI] [PubMed] [Google Scholar]
  44. Reaven G. M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988 Dec;37(12):1595–1607. doi: 10.2337/diab.37.12.1595. [DOI] [PubMed] [Google Scholar]
  45. Reaven G. M., Lithell H., Landsberg L. Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system. N Engl J Med. 1996 Feb 8;334(6):374–381. doi: 10.1056/NEJM199602083340607. [DOI] [PubMed] [Google Scholar]
  46. Rimm E. B., Chan J., Stampfer M. J., Colditz G. A., Willett W. C. Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. BMJ. 1995 Mar 4;310(6979):555–559. doi: 10.1136/bmj.310.6979.555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Scheen A. J., Paquot N., Castillo M. J., Lefèbvre P. J. How to measure insulin action in vivo. Diabetes Metab Rev. 1994 Jul;10(2):151–188. doi: 10.1002/dmr.5610100206. [DOI] [PubMed] [Google Scholar]
  48. Segal K. R., Landt M., Klein S. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes. 1996 Jul;45(7):988–991. doi: 10.2337/diab.45.7.988. [DOI] [PubMed] [Google Scholar]
  49. Skarfors E. T., Lithell H. O., Selinus I., Aberg H. Do antihypertensive drugs precipitate diabetes in predisposed men? BMJ. 1989 Apr 29;298(6681):1147–1152. doi: 10.1136/bmj.298.6681.1147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Storlien L. H., Baur L. A., Kriketos A. D., Pan D. A., Cooney G. J., Jenkins A. B., Calvert G. D., Campbell L. V. Dietary fats and insulin action. Diabetologia. 1996 Jun;39(6):621–631. doi: 10.1007/BF00418533. [DOI] [PubMed] [Google Scholar]
  51. Stout R. W. Insulin and atheroma. 20-yr perspective. Diabetes Care. 1990 Jun;13(6):631–654. doi: 10.2337/diacare.13.6.631. [DOI] [PubMed] [Google Scholar]
  52. Stumvoll M., Nurjhan N., Perriello G., Dailey G., Gerich J. E. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med. 1995 Aug 31;333(9):550–554. doi: 10.1056/NEJM199508313330903. [DOI] [PubMed] [Google Scholar]
  53. Sørensen T. I., Echwald S., Holm J. C. Leptin in obesity. BMJ. 1996 Oct 19;313(7063):953–954. doi: 10.1136/bmj.313.7063.953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Temple R., Clark P. M., Hales C. N. Measurement of insulin secretion in type 2 diabetes: problems and pitfalls. Diabet Med. 1992 Jul;9(6):503–512. doi: 10.1111/j.1464-5491.1992.tb01830.x. [DOI] [PubMed] [Google Scholar]
  55. Unger R. H., Grundy S. Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes. Diabetologia. 1985 Mar;28(3):119–121. doi: 10.1007/BF00273856. [DOI] [PubMed] [Google Scholar]
  56. Yki-Järvinen H. Role of insulin resistance in the pathogenesis of NIDDM. Diabetologia. 1995 Dec;38(12):1378–1388. doi: 10.1007/BF00400597. [DOI] [PubMed] [Google Scholar]
  57. Zavaroni I., Bonora E., Pagliara M., Dall'Aglio E., Luchetti L., Buonanno G., Bonati P. A., Bergonzani M., Gnudi L., Passeri M. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med. 1989 Mar 16;320(11):702–706. doi: 10.1056/NEJM198903163201105. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES